Flexion Therapeutics, Inc.
FLXN
FLXN was delisted on the 18th of November, 2021.
84 hedge funds and large institutions have $370M invested in Flexion Therapeutics, Inc. in 2016 Q3 according to their latest regulatory filings, with 12 funds opening new positions, 36 increasing their positions, 23 reducing their positions, and 9 closing their positions.
101% more call options, than puts
Call options by funds: $3.69M | Put options by funds: $1.84M
57% more repeat investments, than reductions
Existing positions increased: 36 | Existing positions reduced: 23
33% more first-time investments, than exits
New positions opened: 12 | Existing positions closed: 9
31% more capital invested
Capital invested by funds: $282M → $370M (+$88.3M)
4% more funds holding
Funds holding: 81 → 84 (+3)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
+$4.26M |
| 2 |
BIT
BlackRock Institutional Trust
San Francisco,
California
|
+$2.75M |
| 3 |
NHAS
Novo Holdings A/S
Hellerup,
Denmark
|
+$2.5M |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$2.37M |
| 5 |
American Century Companies
Kansas City,
Missouri
|
+$1.39M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Wells Fargo
San Francisco,
California
|
-$13.3M |
| 2 |
GGHC
Gilder Gagnon Howe & Co
New York
|
-$5.44M |
| 3 |
OAM
Oxford Asset Management
Oxford,
United Kingdom
|
-$2.83M |
| 4 |
GH
GAM Holding
Zurich,
Switzerland
|
-$2.21M |
| 5 |
SM
Sabby Management
Miami Beach,
Florida
|
-$1.5M |
FLXN Hedge Fund Activity: Q3 2016 in Review
84 of the 3,759 institutional investors tracked by Wall St. Rank reported a position in Flexion Therapeutics, Inc. (FLXN) for Q3 2016, worth a combined $370M — up 31% from $282M a quarter earlier.
Buyers outnumbered sellers: 12 funds opened new FLXN positions and 9 closed out — a net gain of 3 holders — while 36 added to existing stakes and 23 trimmed.
The largest buyer was BlackRock Fund Advisors, adding an estimated $4.26M. The largest seller was Wells Fargo, cutting an estimated $13.3M.
- 84 institutional investors held Flexion Therapeutics, Inc. (FLXN) as of Q3 2016, up from 81 in Q2 2016.
- Funds reported $370M of Flexion Therapeutics, Inc. stock for Q3 2016, up 31% quarter-over-quarter.
- 12 funds opened new Flexion Therapeutics, Inc. positions in Q3 2016 and 9 closed out, a net change of +3 holders.
- The largest Flexion Therapeutics, Inc. buyer in Q3 2016 was BlackRock Fund Advisors, an estimated $4.26M added.
- The largest Flexion Therapeutics, Inc. seller in Q3 2016 was Wells Fargo, an estimated $13.3M sold.
Based on aggregated 13F filings for Q3 2016.